FINANCIALS

JAZZ Jazz Pharmaceuticals Plc 1232524

Income Statement
Revenue	jazz-20241231	4,068,950,000
Net Income	jazz-20241231	560,120,000
Profit Margin		13.77%

Balance Sheet
Current Assets	4,629,028,000
Assets	12,012,257,000
Current Liabilities	1,038,573,000
Liabilities	7,918,501,000
Equity	4,093,756,000
Shares Out	61,560,000

Cash Flow Statement
Operating Cash Flow	1,395,908,000
Investing Cash Flow	-508,195,000

Market Analysis
Market Cap	12,459,816,488
Price	202.40
BVPS	66.29
PB	2.13
EPS	-5.87
PS	0.42
FCF	887,713,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view JAZZ documents filed with the SEC.

JAZZ Filings Clear

View A List of Tickers